Appili Raises $3.6M, Files Prospectus

As it moves closer to listing its stock on the TSX Venture Exchange, Appili Therapeutics of Halifax has raised an additional $3.6 million by selling shares and warrants through a private placement.
The drug discovery company issued a statement Monday saying it had raised gross proceeds of about $3.6 million through the placement, though the total is lowered somewhat by fees paid to the banks